Characteristics | n = 55 |
Age at diagnosis, median (range) | 61 years (37 – 87) |
Male | 8 (15%) |
Female | 47 (85%) |
Primary tumor | 44 (80%) |
Recurrent tumor | 11 (20%) |
Vulvar cancer | 37 (67%) |
Vaginal cancer | 4 (7%) |
Anal cancer | 14 (26%) |
Patient height, median (range) | 1.63 m (1.42–1.91) |
Patient weight, median (range) | 71 kg (50 – 137) |
FDG activity injected, median (range) | 14.2 mCi (11.4–22.5) |
Fasting blood glucose before image acquisition, median (range) | 100 mg/dL (71 – 222) |
Time from injection to image acquisition, median (range) | 59 min (50 – 96) |
FDG, 18F-fluorodeoxyglucose.